NEW YORK and LONDON, April 25, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies …
PRESS RELEASES
Join Us for a Virtual KOL Event
Join us for a virtual KOL event with Akari Therapeutics, featuring Elias Reichel, MD (Tufts University School of Medicine) who will discuss …
Akari Therapeutics to Host Key Opinion Leader Webinar on Geographic Atrophy and the Potential of Long-Acting PAS-Nomacopan to Address Significant Unmet Needs
NEW YORK and LONDON, April 14, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies …